CVS

What Wall St. Knows About CVS Health Today.

Shares of CVS Health have moved -2.8% today, and are now trading at a price of $67.87. In contrast, the S&P 500 index saw a 0.0% change. Today's trading volume is 2,652,909 compared to the stock's average volume of 8,732,850.

CVS Health Corporation provides health services in the United States. Based in Woonsocket, United States the company has 219,000 full time employees and a market cap of $87,011,377,152. CVS Health currently offers its equity investors a dividend that yields 3.2% per year.

The company is now trading -24.39% away from its average analyst target price of $89.76 per share. The 22 analysts following the stock have set target prices ranging from $69.68 to $131.11, and on average give CVS Health a rating of buy.

Over the last year, CVS shares have gone down by -25.1%, which represents a difference of -38.0% when compared to the S&P 500. The stock's 52 week high is $107.26 per share and its 52 week low is $66.34. With its gross margins declining an average -1.2% over the last 4 years, CVS Health may not have a strong enough business to reverse this trend.

Date Reported Revenue ($ k) Cost of Revenue ($ k) Gross Margins (%) YoY Growth (%)
2022-12-31 322,467,000 267,965,000 16.9 -5.16
2021-12-31 292,111,000 240,063,000 17.82 -2.36
2020-12-31 268,706,000 219,660,000 18.25 2.93
2019-12-31 256,776,000 211,248,000 17.73 n/a
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS